Although antibodies exhibit nanomolar affinities toward protein antigens, the specificity against glycans is very limited. In fact, available antibodies may bind only <4% of the 7000 mammalian glycan antigens; moreover, most of those antibodies have low affinity and exhibit cross-reactivity.